University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Peter Bacchetti, PhD

Peter Bacchetti, PhD

Adjunct Professor, Department of Epidemiology and Biostatistics, UCSF

Cancer Center Program Memberships

Affiliate Member

Education

University of California, Berkeley, California, BA, 1980, Philosophy and Statistics
Stanford University, Stanford, California, MS, 1982, Statistics
University of California, Berkeley, California, PhD, 1987, Biostatistics
 


Professional Experience

  • 11/82-7/85
    Statistician, Department of Epidemiology and Biostatistics, UCSF
  • 8/85-12/87
    Senior Statistician, Department of Epidemiology and Biostatistics, UCSF
  • 1/88-6/93
    Adjunct Assistant Professor, Department of Epidemiology and Biostatistics, UCSF
  • 7/93-7/99
    Adjunct Associate Professor, Department of Epidemiology and Biostatistics, UCSF
  • 11/93-present
    Director, Biostatistical Consulting Unit, Department of Epidemiology and Biostatistics, UCSF
  • 07/99-present
    Adjunct Professor, Department of Epidemiology and Biostatistics, UCSF

Honors & Awards

  • 1980
    Phi Beta Kappa
  • 1980
    Statistics Departmental Citation (outstanding graduating senior), University of California, Berkeley
  • 1988
    First place, Biometric Society 1987-88 student paper competition (Western North American Region)
  • 1998
    Mortimer Spiegelman Award for outstanding contributions to health statistics, American Public Health Association
  • 2004
    Fellow of the American Statistical Association

Selected Publications

  1. Metcalfe J, Bacchetti P, Gerona R, Esmail A, Dheda K, Gandhi M. Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB. ERJ Open Res. 2019 Apr; 5(2).
    View on PubMed
  2. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Ospina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population. AIDS. 2019 Apr 01; 33(5):825-832.
    View on PubMed
  3. Gandhi M, Devi S, Bacchetti P, Chandy S, Heylen E, Phung N, Kuncze K, Okochi H, Kumar R, Kurpad AV, Ekstrand ML. Measuring adherence to antiretroviral therapy via hair concentrations in India. J Acquir Immune Defic Syndr. 2019 Feb 20.
    View on PubMed
  4. Selby K, Jensen CD, Zhao WK, Lee JK, Slam A, Schottinger JE, Bacchetti P, Levin TR, Corley DA. Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study. Clin Transl Gastroenterol. 2019 Feb; 10(2):e00010.
    View on PubMed
  5. Gandhi M, Bacchetti P, SpinelliI MA, Okochi H, Baeten JM, Siriprakaisil O, Klinbuayaem V, Rodrigues WC, Wang G, Vincent M, Cressey TR, Drain PK. Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cut-Off for a Point-of-Care Test. J Acquir Immune Defic Syndr. 2019 Jan 11.
    View on PubMed
  6. Coffey S, Bacchetti P, Sachdev D, Bacon O, Jones D, Opsina-Norvell C, Torres S, Lynch E, Camp C, Mercer-Slomoff R, Lee S, Christopoulos K, Pilcher C, Hsu L, Jin C, Scheer S, Havlir D, Gandhi M. RAPID ART: High virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population. AIDS. 2018 Dec 21.
    View on PubMed
  7. Scully EP, Gandhi M, Johnston R, Hoh R, Lockhart A, Dobrowolski C, Pagliuzza A, Milush JM, Baker CA, Girling V, Ellefson A, Gorelick R, Lifson J, Altfeld M, Alter G, Cedars M, Solomon A, Lewin SR, Karn J, Chomont N, Bacchetti P, Deeks SG. Sex-Based Differences in HIV-1 Reservoir Activity and Residual Immune Activation. J Infect Dis. 2018 Oct 29.
    View on PubMed
  8. Koss CA, Liu AY, Castillo-Mancilla J, Bacchetti P, McHugh C, Kuncze K, Morrow M, Louie A, Seifert S, Okochi H, MaWhinney S, Gandhi M, Anderson PL. Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoring. AIDS. 2018 Sep 24; 32(15):2189-2194.
    View on PubMed
  9. Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort. J Gen Intern Med. 2018 Sep 20.
    View on PubMed
  10. Gandhi M, Ofokotun I, Bacchetti P, Jin C, Ribaudo HJ, Haas DW, Sheth AN, Horng H, Phung N, Kuncze K, Okochi H, Landovitz RJ, Lennox J, Currier JS. Antiretroviral concentrations in hair strongly predict virologic response in a large HIV treatment-naive clinical trial. Clin Infect Dis. 2018 Sep 03.
    View on PubMed
  11. Gandhi M, Bacchetti P, Rodrigues WC, Spinelli M, Koss CA, Drain PK, Baeten JM, Mugo NR, Ngure K, Benet LZ, Okochi H, Wang G, Vincent M. Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence. EClinicalMedicine. 2018 Aug-Sep; 2-3:22-28.
    View on PubMed
  12. Lee SA, Elliott JH, McMahon J, Hartogenesis W, Bumpus NN, Lifson JD, Gorelick RJ, Bacchetti P, Deeks SG, Lewin SR, Savic RM. Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial. Clin Pharmacol Ther. 2018 Aug 23.
    View on PubMed
  13. Das B, Dobrowolski C, Luttge B, Valadkhan S, Chomont N, Johnston R, Bacchetti P, Hoh R, Gandhi M, Deeks SG, Scully E, Karn J. Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir. Proc Natl Acad Sci U S A. 2018 08 14; 115(33):E7795-E7804.
    View on PubMed
  14. Koss CA, Liu AY, Castillo-Mancilla J, Bacchetti P, Mchugh C, Kuncze K, Morrow M, Louie A, Seifert S, Okochi H, Mawhinney S, Gandhi M, Anderson PL. Similar tenofovir hair concentrations in men and women after directly-observed: dosing of TDF/FTC: implications for PrEP adherence monitoring. AIDS. 2018 Jul 12.
    View on PubMed
  15. Radtke KK, Bacchetti P, Anastos K, Merenstein D, Crystal H, Karim R, Weber KM, Edmonds A, Sheth AN, Fischl MA, Vance D, Greenblatt RM, Rubin LH. Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study. J Acquir Immune Defic Syndr. 2018 Jun 01; 78(2):202-208.
    View on PubMed
  16. Hecht FM, Moskowitz JT, Moran P, Epel ES, Bacchetti P, Acree M, Kemeny ME, Mendes WB, Duncan LG, Weng H, Levy JA, Deeks SG, Folkman S. A randomized, controlled trial of mindfulness-based stress reduction in HIV infection. Brain Behav Immun. 2018 Oct; 73:331-339.
    View on PubMed
  17. Phung N, Kuncze K, Okochi H, Louie A, Benet LZ, Ofokotun I, Haas DW, Currier JS, Chawana TD, Sheth AN, Bacchetti P, Gandhi M, Horng H. Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2018 Mar 15; 32(5):431-441.
    View on PubMed
  18. Tamraz B, Huang Y, French AL, Kassaye S, Anastos K, Nowicki MJ, Gange S, Gustafson DR, Bacchetti P, Greenblatt RM, Hysi PG, Aouizerat BE. A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair. Clin Pharmacol Ther. 2018 Nov; 104(5):949-956.
    View on PubMed
  19. Uribe LA, Bacchetti P, Gelman N, Burchard E, Fitch M, Hellerstein M, Khalili M. Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C. Alcohol Clin Exp Res. 2018 Mar; 42(3):492-499.
    View on PubMed
  20. Baxi SM, Vittinghoff E, Bacchetti P, Huang Y, Chillag K, Wiegand R, Anderson PL, Grant R, Greenblatt RM, Buchbinder S, Gandhi M, Liu AY. Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial. PLoS One. 2018; 13(1):e0190118.
    View on PubMed

Go to UCSF Profiles, powered by CTSI